Welcome to our dedicated page for Viavi Solutions SEC filings (Ticker: VIAV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Viavi Solutions Inc. filings document operating results, material events, governance actions and capital-structure matters for a Nasdaq-listed technology company. Its Form 8-K disclosures include quarterly financial results, material definitive agreements, restructuring-related exit and disposal cost disclosures, and amendments to governing documents.
VIAVI regulatory records also cover senior convertible note transactions, exchanges of prior convertible notes, proxy and governance disclosures, shareholder voting matters, director elections, officer exculpation provisions, common stock registration details and related risk, ownership and corporate-control information.
VIAVI Solutions Inc. reported an updated institutional ownership filing from T. Rowe Price Investment Management, Inc. In this amended Schedule 13G, T. Rowe Price reports beneficial ownership of 8,497,432 shares of VIAVI common stock, representing 3.8% of the outstanding class as of 12/31/2025.
T. Rowe Price has sole voting power over 8,443,257 shares and sole dispositive power over 8,497,432 shares, with no shared voting or dispositive power. The firm states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of VIAVI.
A shareholder has filed a Rule 144 notice to sell 13,901 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ, with an approximate sale date of 02/13/2026. The filing lists an aggregate market value of $369,628.98 for these shares and notes that 231,389,345 shares of the same class are outstanding. The securities to be sold were acquired as restricted stock from the issuer on several dates between 2014 and 2024.
SCRIVANICH LUKE M reported open-market sale transactions in a Form 4 filing for VIAV. The filing lists transactions totaling 13,901 shares at a weighted average price of $26.59 per share. Following the reported transactions, holdings were 49,980 shares.
VIAVI Solutions’ President & CEO Oleg Khaykin reported share sales in a Form 4 filing. On February 10, 2026, he sold 42,767 shares of VIAVI common stock at a weighted average price of $27.50 per share in multiple trades.
On the same date, an account held by his spouse, reported as indirectly owned, sold an additional 20,000 shares at a weighted average price of $27.51 per share. After these transactions, Khaykin beneficially owned 1,592,854 shares directly and 20,238 shares indirectly through his spouse’s holdings.
VIAV has a Rule 144 notice covering the planned sale of 20,000 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of 550134.00. The issuer reports 231,389,345 common shares outstanding, and the sale is targeted for 02/10/2026 on NASDAQ.
The 20,000 shares were acquired as restricted stock from the issuer on 08/28/2024. The filing also lists prior sales in the last three months by named holders including Oleg Khaykin, Oleg Khaykin Irrevocable Trust, and Helen Khaykin Irrevocable Trust, with individual transactions such as 73,250 shares sold for 1923120.15 on 02/09/2026.
A shareholder of VIAV filed a notice of proposed sale of 42,767 shares of common stock, with an aggregate market value of $1,176,113.88, through Morgan Stanley Smith Barney LLC on or about 02/10/2026 on the NASDAQ market.
The filing notes that 231,389,345 common shares were outstanding at the time of the notice; this is a baseline figure, not the amount being sold. The seller previously acquired several blocks of restricted stock directly from the issuer between 2019 and 2020.
The notice also lists prior sales of the issuer’s common stock during the past three months by the same person and related irrevocable trusts, including 73,250 shares sold on 02/09/2026 for $1,923,120.15 and 74,315 shares sold on 02/04/2026 for $1,968,024.69.
Wellington Management Group and affiliates report a 4.93% beneficial stake in Viavi Solutions Inc. common stock as of December 31, 2025. They report beneficial ownership of 10,999,595 shares, with shared voting power over 8,387,256 shares and shared dispositive power over 10,999,595 shares.
The securities are owned of record by clients of Wellington investment advisers, which have the right to receive dividends and sale proceeds. No individual client is reported to hold more than five percent of the class. The holdings are certified as being held in the ordinary course of business and not for influencing control of Viavi.
Form 144 reports a planned sale of 73,250 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of 1,923,120.15, to be sold on or about 02/09/2026 on the NASDAQ exchange.
The shares were acquired as restricted stock and performance shares on 08/28/2020 and 09/22/2022. The filing also lists multiple sales of common shares over the prior three months by Oleg Khaykin and related irrevocable trusts, with individual transactions ranging up to 74,315 shares and gross proceeds exceeding 1,700,000.00 in a single sale.
Viavi Solutions Inc. President & CEO Oleg Khaykin reported a sale of common stock. On February 9, 2026, he sold 73,250 shares of Viavi common stock at a weighted average price of $26.25 per share, executed in multiple trades between $26.25 and $26.26.
After this transaction, Khaykin beneficially owned 1,635,621 shares of common stock directly. In addition, 40,238 shares were held indirectly as common stock by his spouse, which are reported as indirect beneficial ownership.
Viavi Solutions Inc. President and CEO Oleg Khaykin reported open‑market sales of company common stock. On February 6, 2026, he sold 29,887 shares at $26.30 per share and 40,679 shares at $26.25 per share, with the latter price disclosed as a weighted average for trades between $26.24 and $26.30.
Following these transactions, Khaykin beneficially owned 1,708,871 shares of Viavi common stock directly. In addition, 40,238 shares were reported as indirectly owned, held by the reporting person’s spouse.